Max Pemberton 7 November 2015 9:00 am
A new drug could reduce new infections to zero – so why hasn’t the NHS backed it yet?
Australia's best political analysis - straight to your inbox
Michael de Percy
Neil Brown
The Spectator Australia
David van Gend
Francis Pike
Andrew Tettenborn
The Spectator Australia's Morning Double Shot delivers a hearty breakfast of news and views straight to your inbox
Weekly round up of the best Flat White blogs - delivered straight to your inbox